Stocks recovered early gains and touched record highs after the Institute for Supply Management corrected its monthly index to show a modest gain from April instead of a contraction in manufacturing. The group twice issued corrections Monday, first pointing to a software glitch and then detailing seasonal-adjustment issues. But after touching the new high, equities flat-lined into the close leaving the Dow Industrials and S&P 500 with very modest gains and Nasdaq Composite lower in back-to-back sessions.
Shares of Google ( GOOG ) and Apple ( AAPL ) both contributed to the lower close in the tech-heavy index as GOOG shares reacted negatively to China's increased censorship of the search engine leading into the anniversary of the Tiananmen Square protests, while Apple shares reflected investors' disappointment with the lack of innovative products introduced at the developer's conference.
But the big news today was the repeated revisions to the ISM manufacturing index for May that reverberated through Wall Street. The ISM initially reported a decline to 53.2, missing estimates of 55.5 and down from 54.9 in April. This was revised to 56.0, and then revised again to 55.4 as the index was recalculated to include seasonal adjustments.
The fluctuations in the ISM and its impact on equities overshadowed a greater-than-expected increase in the May Purchasing Managers Index to 56.4, and a 0.2% gain in April construction spending, missing estimates for +0.7%.
Here's where the markets stand at the close:
US MARKETS
Dow Jones Industrial Index was up 26 points (+0.16%) at 16,743
S&P 500 was up 1.4 point (+0.07%) at 1,924
Nasdaq Composite Index was down 5 points (-0.13%) at 4,237
GLOBAL SENTIMENT
FTSE 100 was up 0.29%
Nikkei 225 was up 2.07%
Hang Seng Index was up 0.31%
Shanghai China Composite Index was up 0.07%
UPSIDE MOVERS
(+) EVRY (58.18%) Reached a forebearance agreement with lenders and amended its asset-backed loan agreement.
(+) GIGA (+139.67%) Filter order from unnamed aerospace company
(+) ARIA (+7.43%) Details several positive study results
DOWNSIDE MOVERS
(-) BEBE (-16.81%) CEO sold 141,000 shares
(-) ACAT (-8.79%) Downgraded at Baird to Neutral from Outperform, PT cut by $7
(-) CLVS (-6.76%) Patients develop high blood sugar in lung cancer study
(-) PBYI (-25.42%) PB272 results for breast cancer metastasized to the brain
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
